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Chordin is a bone morphogenetic protein (BMP) inhibitor that has been identified as a factor dorsalizing the Xenopus
embryo. A novel secreted protein, CHL (for chordin-like), with significant homology to chordin, was isolated from mouse
bone marrow stromal cells. Injection of CHL RNA into Xenopus embryos induced a secondary axis. Recombinant CHL
protein inhibited the BMP4-dependent differentiation of embryonic stem cells in vitro and interacted directly with BMPs,
similar to chordin. However, CHL also weakly bound to TGFbs. In situ hybridization revealed that the mouse CHL gene,
located on the X chromosome, was expressed predominantly in mesenchyme-derived cell types: (1) the dermatome and limb
bud mesenchyme and, later, the subdermal mesenchyme and the chondrocytes of the developing skeleton during
embryogenesis and (2) a layer of fibroblasts/connective tissue cells in the gastrointestinal tract, the thick straight segments
of kidney tubules, and the marrow stromal cells in adults. An exception was expression in the neural cells of the olfactory
bulb and cerebellum. Interestingly, the spatiotemporal expression patterns of CHL were distinct from those of chordin in
many areas examined. Thus, CHL may serve as an important BMP regulator for differentiating mesenchymal cells,
especially during skeletogenesis, and for developing specific neurons. © 2001 Academic Press
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eINTRODUCTION
Bone morphogenetic proteins (BMPs) belong to the trans-
forming growth factor (TGF)b superfamily and were origi-
ally identified as factors promoting the ectopic formation
f cartilage and bone (reviewed in Wang, 1993). BMPs are
lso known to play an essential role during the early
mbryogenesis of Drosophila, Xenopus, zebrafish, and
ammals (reviewed in Harland and Gerhart, 1997). More-
ver, BMPs are involved in cell-type specification during
he organogenesis phase of embryogenesis (reviewed in
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Cell Biology, Inflammation Research, Am-
en Inc., MS: 14-1-D, One Amgen Center Drive, Thousand Oaks, CAA1320. Fax: 1-805-447-1982. E-mail: naoki.nakayama@amgen.com.
372ogan, 1996). In any case, BMPs are pleiotropic factors, and
he precise concentration of active BMP seems to be impor-
ant for rendering a particular biological effect. In fact, an
ctivity gradient of BMP is formed during embryogenesis in
rosophila as well as in Xenopus, which leads to the
eneration of different cell types, depending on the location
i.e., the local BMP concentration) (reviewed in Dale and
ardle, 1999; Podos and Ferguson, 1999).
The active BMP concentration is controlled in part
hrough the influence of BMP inhibitors. Several BMP
inding proteins have been described: short gastrulation/
hordin (Francois et al., 1994; Pappano et al., 1998; Sasai et
l., 1994; Schulte-Merker et al., 1997), noggin (Smith and
arland, 1992; Zimmerman et al., 1996), and cerberus (Belo
t al., 1997; Biben et al., 1998; Bouwmeester et al., 1996).
mong them, chordin and noggin are known to inhibit the
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373A Novel Chordin-like Protein Inhibitor for BMPsactivity of bound BMP by preventing it from binding to its
receptor (Piccolo et al., 1996; Zimmerman et al., 1996).
Chordin is a secreted protein produced from the Spemann’s
organizer of the Xenopus embryo and functions as a dorsal-
ization factor by antagonizing the ventralizing factor,
BMP4. The binding affinity of chordin to BMP4 is specific
and tight (Piccolo et al., 1996), and proteolysis seems to be
equired to effectuate the release of bound BMP4. The
hordin polypeptide contains four cysteine-rich units des-
gnated procollagen repeats (CRs), which are also found in a
ariety of extracellular matrix proteins, such as collagen
nd thrombospondin. The first and third CRs (CR1 and
R3) of chordin are responsible for BMP binding (Larrain et
l., 2000). Proteolytic degradation of chordin is accom-
lished by a metalloprotease, Tolloid or BMP1, that liber-
tes both CR1 and CR4 (Piccolo et al., 1997; Scott et al.,
999).
It is conceivable that, if expressed at the same time and
ocation, any of the BMP binding inhibitors would function-
lly compensate for each other. This is the case for chordin
nd noggin in the mouse (Bachiller et al., 2000; Brunet et
l., 1998; McMahon et al., 1998). Mouse chordin mRNA is
rst detected in the anterior primitive streak and then in
he node and axial mesoderm. At the midgastrula stage,
hordin expression overlaps with that of noggin. Muta-
ional analyses have shown that the early embryonic func-
ions of chordin and noggin are individually dispensable for
mbryonic development. However, chordin is essential for
nner and outer ear development as well as for pharyngeal
nd cardiovascular organization (Bachiller et al., 2000).
Similarly, noggin null-mutant mice display multiple devel-
opmental defects occurring at late stages of embryogenesis,
including limb and digit defects caused by chondrocyte
hyperplasia (Brunet et al., 1998; McMahon et al., 1998). In
contrast, double mutants show early embryonic phenotypes
(Bachiller et al., 2000). Thus, these BMP inhibitors seem to
share biological roles during early embryogenesis, whereas
the roles of the individual inhibitors become specialized in
later stages of development, so that some functions of
chordin are no longer compensated by noggin or other BMP
inhibitors.
Functional redundancy often occurs in members of the
same gene family. Cerberus is known to form a large gene
family: cerberus/Cer1 (Biben et al., 1998; Bouwmeester et
al., 1996; Shawlot et al., 1998), DAN (Ozaki et al., 1996;
Stanley et al., 1998), Gremlin/Drm (Hsu et al., 1998; Topol
et al., 1997), and Dte (Pearce et al., 1999). It has recently
been shown that noggin also forms a family in zebrafish
(Fuerthauer et al., 1999). However, thus far, no functional
redundancy has been demonstrated within these families.
On the contrary, differences in the spatial as well as
temporal order of expression during embryogenesis have
been demonstrated, suggesting a different biological role for
each member of the family. In the case of zebrafish noggin,
noggin1 is expressed earliest and is active in dorsalizing the
embryo, while noggin3 is the latest expressing member and
probably functions during organogenesis. Recently, a large
Copyright © 2001 by Academic Press. All rightsecreted Xenopus protein containing 27 CRs, which shows
chordin-like dorsalizing activity in Xenopus embryos, was
identified (Matsui et al., 2000). Here, we provide evidence
that a novel chordin family member, CHL (for chordin-
like), is a BMP inhibitor, and the gene is localized on the X
chromosome and is expressed preferentially in mesenchy-
mal cell lineages with spatial and temporal patterns distinct
from those of chordin. Potential roles of CHL during several
organogenic processes are also discussed.
MATERIALS AND METHODS
Cells and reagents. Polymerase chain reaction (PCR) and
cDNA synthesis were performed with Advantage Taq (Clontech,
Palo Alto, CA) and the Superscript cDNA library kit (Gibco/BRL,
Gaithersburg, MD), respectively, according to the manufacturer’s
recommendations. Other enzymes were purchased from New En-
gland BioLabs (Beverly, MA) or Boehringer Mannheim (Indianapo-
lis, IN). The human erythropoietin (EPO) cDNA was kindly pro-
vided by S. Wooden (Amgen).
The E14 ES cells and the OP9 stromal cell line were obtained and
cultured as described (Nakayama et al., 1998, 2000). The human
kidney epithelial cell lines, 293 and 293T, were maintained in
Dulbecco’s modified essential medium (DMEM, Gibco/BRL)
supplemented with 10% fetal calf serum (FCS, Hyclone, Logan,
UT) at 37°C under 5% CO2. All tissue culture flasks and plates
were from Falcon (Franklin Lakes, NJ).
Recombinant human BMP4, BMP5, BMP6, activin A, TGFb2,
and BMPR1BFc were purchased from R&D Systems (Minneapolis,
MN). The corresponding antibodies used for Western blot detection
were the anti-human BMP4 mouse monoclonal antibody from
Chemicon (Temecula, CA), the anti-human BMP5 goat polyclonal
antibody from R&D, the anti-human BMP6 mouse monoclonal
antibody from Chemicon, the anti-human activin A goat poly-
clonal antibody from R&D, and the anti-human TGFb2 goat
polyclonal antibody from R&D. A human IgG Fc control was
obtained from Zymed (South San Francisco, CA). The monoclonal
antibody for mouse CD34 (clone RAM34) conjugated with fluores-
cein isothiocyanate (FITC) was purchased from Pharmingen (San
Diego, CA). Phycoerythrin (PE)-conjugated monoclonal antibodies
for mouse CD31 (clone MEC13.3) and CD45 (clone 30F11) were
also purchased from Pharmingen.
Isolation of mouse CHL cDNAs. Normalized cDNAs were
prepared with poly(A)1 RNA isolated from OP9 cells according
to the PCR-based normalization procedure (Takahashi and Ko,
1994). Small fragments (500 –1000 bp) were used to construct a
library for yeast-based signal sequence trap screening (Jacobs et
al., 1997; Klein et al., 1996). An unnormalized cDNA library was
also constructed in pSPORT1 (Gibco/BRL). From one pool of the
normalized OP9 library (3 3 105 independent clones) screened, a
DNA fragment encoding a putative NH2-terminal amino acid
sequence of a protein with significant homology to chicken
chordin, which was designated CHL, was identified by a Blast
search (Genomics Computer Group, Madison, WI). Using this
partial cDNA as a probe, the corresponding full-length cDNA
clone, mCHL(s2), was isolated from the unnormalized cDNA
library (pSPORTmCHL(s2)). Furthermore, another cDNA clone
designated mCHL(l3) that potentially encoded a different form of
CHL was isolated from the mouse E15.5 embryo library (GIBCO/
BRL). For stable expression, the full-length mCHL(s2) cDNA was
s of reproduction in any form reserved.
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374 Nakayama et al.cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) to obtain
pcDNAmCHL(s2), and for transient expression, the same cDNA
was cloned into an SRa-based expression plasmid (Takebe et al.,
1988) to yield pSRamCHL(s2). As a negative control, pSRahEPO
arrying the human EPO cDNA in place of mCHL(s2) was also
onstructed.
Isolation of human CHL cDNAs. Total RNA was isolated from
at prostate, poly(A)1 RNA was purified, and normalized cDNA
inserts were prepared as described above. A longer range of cDNAs
(. 1000 bp) was used to construct a cDNA library for expression
sequence tag (EST) analysis (Adams et al., 1991). A sequence
FIG. 1. Schematic representation of CHL and chordin gene produc
hordin (CHD) gene products. CR and SP stand for the procollage
MP1/Tolloid cleavage sites is indicated with an asterisk. The CR1
ndicated with black boxes. The two sites, at which amino acid seq
n parentheses. The dE indicates E95/96 missing in the l2, l4, and s2
nd l4 forms. (B) Amino acid sequences of the human CHL(l1) and
Rs are indicated as boxes. The E23 indicated by the vertical ar
mCHL(s2)-FLAG protein. The amino acid with an asterisk corresp
hCHL(l4) as well as in mCHL(s2) and the GKKAK stretch delet
representation of the partial intron–exon structure of the hCHL gen
AL049176. The vertical bars are exons, which correspond to thic
underneath (CHL(s) and CHL(l)). The thin lines of the transcripts in
by an alternative splicing acceptor at the junction of intron 4 (Int4
generated at the junction between exon 9 (Ex9) and intron 9 (Int9).
the 39-UTR of the CHL(s) transcript.containing a partial ORF almost identical to that of the mCHL
Copyright © 2001 by Academic Press. All rightcDNA was identified and was used as a probe to isolate full-length
human CHL cDNAs. Screening of human prostate and fetal brain
cDNA libraries (Stratagene, La Jolla, CA) resulted in four different
forms of human CHL cDNAs, designated hCHL(l1) to hCHL(l4).
All were cloned into pcDNA3.1 to yield pcDNAhCHL(l1),
pcDNAhCHL(l2), pcDNAhCHL(l3), and pcDNAhCHL(l4). To con-
struct hCHL(s1) and hCHL(s2), the exon-9–intron 9 boundary
region was first amplified by PCR with the sense primer 59-
AGCAAGAGTGTAAGAAAATCCAC-39 and the antisense primer
59-AGAATCTCAGTCAACCAAAAGC-39 using human genomic
DNA as the template. The amplified fragment was then cloned into
) Schematic representation of mouse CHL (CHL(s) and CHL(l)) and
peat and the signal peptide, respectively. The cluster of putative
CR3 in mouse CHL are homologous with CR3 of mouse chordin,
e variations were found in the CHL ORF, are shown by dE and d5
s of CHL, and d5 indicates the GKKAK sequence deleted in the l3
(l4) and mouse CHL(l3) and CHL(s2) protein precursors. The three
was determined as the NH2-terminal amino acid of the mature
to the potential BMP1/Tolloid cleavage site. The E95/96 missing in
hCHL(l4) are indicated with black backgrounds. (C) Schematic
d transcripts. The top is the partial genomic organization based on
rizontal bars/arrows in the two potential CHL transcripts shown
te splicing. The E95/96 deletion mutation, indicated as dE, is created
exon 5 (Ex5). The GKKAK deletion mutation, indicated as d5, is
gray vertical bar in intron 9 indicates the region corresponding tots. (A
n re
and
uenc
form
CHL
row
onds
ed in
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ThepCR II-TOPO (Invitrogen), excised with ClaI and NotI, and transferred
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375A Novel Chordin-like Protein Inhibitor for BMPsto the ClaI–NotI sites of pcDNAhCHL(l1) and pcDNAhCHL(l2) to
obtain pcDNAhCHL(s1) and pcDNAhCHL(s2), respectively.
Construction of the FLAG-tagged mouse CHL(s2) and chordin:
mCHL(s2)-FLAG and mCHD-FLAG. The mCHL(s2) ORF was
mutated to replace the stop codon with a BamHI site by PCR using
the sense primer 59-GCTAGCGGCCGCGCCACCATGGATGG-
CATGAAATACATCATTTC-39 and the antisense primer 59-
GGTACCGGATCCACCAAAGGCAGGGCCTCCAGC-39. The
amplified DNA fragment was digested with NotI and BamHI and
was then inserted into the NotI–BamHI sites of the pFLAG-
CMV-5a expression vector (Sigma) to attach the FLAG sequence in
frame with the mCHL(s2) sequence at its COOH-terminus
(mCHL(s2)-FLAG). The resultant plasmid was designated pFLAG-
mCHL(s2).
Next, mouse chordin cDNA was isolated by reverse transcrip-
tase (RT)–PCR from the mouse E7 embryo cDNAs (Clontech, Palo
Alto, CA) using the sense primer 59-GCTAGCGGCCGCGCC-
ACCATGCCGAGCCTCCCGGCCCCG-39 and the antisense
primer 59-GGATCCGTCGACGGAGTGCTCCGCTTCTTTCTC-
CAG-39. The amplified PCR product was digested with NotI and
SalI and was then inserted into the NotI–SalI sites of pFLAG-CMV-
5a, which resulted in a COOH-terminal FLAG fusion protein of the
mouse chordin (mCHD-FLAG), to yield pFLAGmCHD.
Production and detection of the recombinant mouse CHL(s2)
and chordin proteins. The FLAG-tagged proteins were detected
by direct Western blot analysis with 10 mg/ml of the anti-FLAG
ouse monoclonal antibody M2 (Sigma), according to the manu-
acturer’s recommendations. Rabbit polyclonal antibodies for
CHL and mouse chordin were raised with synthetic peptides
ased on the NH2-terminal amino acid sequences of their presump-
ive mature proteins: NH2-SKTEQVKHSDTYC-COOH for mCHL
and NH2-ALPIRSEKEPLPVRGAAGC-COOH for chordin (Harlow
and Lane, 1988). The resulting antisera were either used directly or
subjected to affinity purification with the corresponding peptides
(Harlow and Lane, 1988).
To establish cell lines stably expressing the mCHL(s2)-FLAG or
mCHD-FLAG protein, 293 cells were transfected with linearized
pFLAGmCHL(s2) or pFLAGmCHD mixed with linearized pKJ1
(Adra et al., 1987), using the calcium phosphate method (Sambrook
et al., 1989). Stable transfectants were then selected in 570 mg/ml
G418 (Gibco/BRL). The expression levels of the corresponding
FLAG-tagged protein, in both the serum-free conditioned media
(DMEM, 48 h) and the cell lysates, were compared by Western blot
analysis using the M2 antibody or the affinity-purified anti-NH2-
terminal peptide antibody (diluted 1:500 to 1:1000) (Harlow and
Lane, 1988). Conditioned media were concentrated 10-fold by
Centricon ultrafiltration (Millipore, Bedford, MA) before Western
blotting. The proteins were visualized with peroxidase-conjugated
anti-mouse or anti-rabbit IgG secondary antibody (Pierce, Rock-
ford, IL) and the chemiluminescent ECL kit (Amersham/
Pharmacia, Piscataway, NJ).
Similarly, transient transfection-based expression was carried
out with 293T cells using the SuperFect transfection reagent
(Qiagen, Valencia, CA) according to the manufacturer’s suggested
protocol. Twenty-four hours later, the medium was changed to
serum-free media, such as 293 SFM II (Gibco/BRL), DMEM, and
DMEM with 50 mg/ml iron-saturated human transferrin (Sigma)
nd 10 mg/ml bovine insulin (Boehringer Mannheim), and the cells
were cultured for another 48 h. Tenfold concentrated conditioned
media were then analyzed by Western blotting. c
Copyright © 2001 by Academic Press. All rightPartial purification of the FLAG-tagged mouse CHL(s2) and
chordin proteins. For midscale preparation, the stable clones
were expanded in suspension using 293 SFM II in a 3-liter spinner
flask, and 3-day conditioned media for mCHL(s2)-FLAG and 6-day
conditioned media for mCHD-FLAG were collected. An expression
level of approximately 0.1–0.2 mg/ml was obtained. The FLAG-
agged proteins were partially purified by a single step of affinity
hromatography using the anti-FLAG M2 affinity gel (Sigma)
ccording to the manufacturer’s recommendations. The protein
FIG. 2. Secondary axis formation by mCHL(s2). Injection of 30 pg
of each RNA made in vitro from pcDNAmCHL(s2) into two
blastomeres of four-cell stage Xenopus embryos resulted in axis
duplication in 48 h (A). In contrast, uninjected embryos showed
normal development (B).oncentration of each preparation was determined by Western blot
s of reproduction in any form reserved.
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376 Nakayama et al.analysis with M2 and comparison with the FLAG bacterial alkaline
phosphatase standard (Sigma).
Co-immunoprecipitation analysis. Immunoprecipitation was
performed as described (Piccolo et al., 1996). Briefly, for the high
concentration conditions, 0.4 mg mCHL(s2)-FLAG or 1.2 mg
mCHD-FLAG was mixed with 0.2 mg of BMP, activin A, or TGFb2
in 1 ml of binding buffer, and the solution was incubated for 1 h at
4°C. Then, either 1.5–4 mg of affinity-purified anti-peptide anti-
ody or 40 ml of crude antisera was added, and the solution was
incubated for another 1 h. Next, 20 ml protein A or 30 ml of protein
/G plus agarose beads (Santa Cruz) was added, and the mixture
as incubated for another 3 h to overnight. For the low concentra-
ion conditions, 0.1 mg of mCHL(s2)-FLAG or 0.3 mg of mCHD-
LAG was mixed with 90–100 ng of BMP or activin A, and the
eaction was processed in the same way. To demonstrate the role of
HL in BMP4 binding to the BMP receptor (BMPR), 100 ng of BMP4
nd various amounts of mCHL(s2)-FLAG were mixed in 1 ml of
inding buffer, and then 1 mg of BMPR1BFc or IgG Fc was added.
he resulting BMPR complex was precipitated directly with 20 ml
of protein A beads. The isolated immunocomplexes were electro-
phoresed through SDS–polyacrylamide gels under reducing condi-
tions and then were blotted onto nitrocellulose membranes. The
filter was treated with 0.4 mg/ml anti-BMP4, 0.1 mg/ml anti-BMP5,
0.1 mg/ml anti-BMP6, 0.4 mg/ml anti-activin A, or 1 mg/ml anti-
TGFb2 antibody for 2 h at room temperature, and the bound
antibodies were visualized as described.
Ectopic axis formation in Xenopus embryo. To examine the
mouse and human CHL protein activities, pcDNAmCHL(s2),
pcDNAhCHL(l1), pcDNAhCHL(l2), pcDNAhCHL(s2), and
pcDNAhCHL(s2) were linearized with NotI, and capped mRNAs
were synthesized with T7 RNA polymerase using the mMESSAGE
mMACHINE kit (Ambion, Austin TX) and were quantified as
described (Nishinakamura et al., 1999). For mCHL(s2)-FLAG, the
EcoRI–ScaI fragment of pFLAGmCHL(s2) was cloned into the
EcoRI–NotI sites of pBluescript RN3 (Lemaire et al., 1995), linear-
ized with SfiI, and transcribed with T3 RNA polymerase using the
mMESSAGE mMACHINE kit. For mCHD-FLAG, the NotI–ScaI
ragment of pFLAGmCHD was introduced into the NotI–SmaI
ites of the pBluescript (SK1) vector (Stratagene), which was then
linearized with ClaI and transcribed in the same way. As a negative
ABLE 1
econdary Axis Formation by Different Forms of CHL
Type of CHL
injected
Embryos wi
0 10
ninjected 0/31 (0)
F1
CHD-FLAGa
mCHL(s2) 20/26 (77)
mCHL(s2)-FLAGb
CHL(l1)
CHL(l2)
CHL(s1)
CHL(s2)
a pBluescript (SK1) vector background.
b pBluescript RN3 vector background.control, elongation factor 1 (EF1) RNA was synthesized using the w
Copyright © 2001 by Academic Press. All righttemplate included in the kits. Xenopus embryos were also prepared
for injection as described (Nishinakamura et al., 1999). Five nano-
liters of each RNA was injected into two ventral blastomeres of a
four-cell stage embryo. After the injection, the embryos were
cultured in 10% Steinberg’s solution for 48 h and were then scored
for the ectopic axis.
In vitro differentiation of embryonic stem cells under serum-
free conditions. Briefly, E14 embryonic stem (ES) cells were
transferred to a gelatin-coated plate, adjusted for 2 days in serum-
free medium, and then subjected to differentiation in serum-free
methylcellulose medium in the presence of 0.6 ng/ml BMP4 as
described (Nakayama et al., 2000). Embryoid bodies were collected
on day 7 and were dissociated with collagenase. The cells were
stained with monoclonal antibodies for hematopoietic progenitor
cell markers, such as CD31, CD34, and CD45, as described
(Nakayama et al., 2000). The stained samples were analyzed on a
FACScan (Becton–Dickinson, San Jose, CA).
In situ hybridization and Northern blot analyses. Northern
blotting was performed (Sambrook et al., 1989) with multiple
mouse tissue Northern blots purchased from Clontech, using the
32P-labeled NotI–BamHI fragment from pFLAGmCHL(s2) that con-
tained the entire ORF of mCHL(s2) as a probe. The chordin
transcript was detected on the same blots with the 32P-labeled
NotI–SalI fragment from pFLAGmCHD containing the intact ORF
of mouse chordin. For detecting the mCHL(s)-specific transcripts, a
probe (designated the intron 9 probe) was made by PCR with the
primers 5 9 -CCTGCCTTTGGTTGAATGAG-3 9 and 5 9 -
GGAGATAGAGGTTAGATAGTAG-39, which were derived from
the nucleotide sequence of the 39-untranslated region (UTR) of the
mCHL(s2) cDNA.
In situ hybridization to embryonic and adult mouse tissue
sections was carried out according to Wilcox (1993). For the CHL
probe, the ClaI–NotI region of pSPORTmCHL(s2) was removed to
obtain pSPmCHL59, which was then linearized with EcoRI. The
antisense RNA was synthesized with SP6 RNA polymerase. For
chordin, the 1.4-kb BamHI–BglII fragment of pFLAGmCHD was
transferred into the BamHI site of the pBluescript (SK2) vector
Stratagene), which was linearized with EcoRI. The antisense RNA
is duplication/total injected embryos (%)
30 1000 pg RNA/blastomere
0/23 (0)
19/23 (83)
26/30 (87)
15/19 (79)
19/41 (46)
13/34 (38)
15/37 (41)
33/40 (83)th axas synthesized with T3 RNA polymerase.
s of reproduction in any form reserved.
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377A Novel Chordin-like Protein Inhibitor for BMPsCloning of the mouse CHL gene and the chromosomal localiza-
tion. The chromosomal location of the mouse CHL gene was
determined by Genome Systems, Inc. (St. Louis, MO), using the
fluorescence in situ hybridization (FISH) technique of Shi et al.
(1997). The probe was a BAC clone, F1038, isolated from the mouse
ES-129/SvJ II BAC chromosome DNA library (Genome Systems) by
PCR using the sense primer 59-TTACCACCAGTGAAC-
AATAAGG -39 and the antisense primer 59-CTTGAGACCAC-
AGTATACATTCC-39, which correspond to the second CR
domain of mCHL(s2), and with the sense primer 59-AGTG-
CCCAGCTTTAGTCCAC-39 and the antisense primer 59-GTT-
CTGTTTTGCTTCCTTCTAG-39, which cover the 59-UTR and the
signal peptide region. To determine the location of the mouse CHL
gene on the X chromosome, the X centromere-specific P1 clone
(No. 6856) was also used as a cohybridization probe (Shi et al.,
1997). A total of 80 metaphase cells were analyzed, and of the 72
that exhibited specific labeling,10 were used for cohybridization
experiments.
RESULTS
Cloning of a cDNA Encoding a Novel Chordin-like
Gene Product from the Mouse Bone Marrow
Stromal Cell Line OP9
The OP9 stromal cell genomics resulted in a cDNA
encoding a 333-amino-acid protein precursor consisting
of a potential signal peptide followed by three CRs
similar to the chordin CRs. The homology with the
chordin CRs ranged from 40 to 53% by a Blast search,
which was statistically significant compared with the
CRs of other proteins, such as thrombospondin and
collagen (data not shown). Therefore, the predicted pro-
tein was designated CHL for chordin-like (Fig. 1A). Dur-
ing the course of the full-length mouse CHL (mCHL)
cDNA cloning, a partial clone encoding a variant of
mCHL was identified from an E15.5 mouse embryo
cDNA library. This had an insertion of one glutamate
residue at position 96 (E96) and carried a longer COOH-
erminal sequence (Fig. 1B). Assuming that both forms
hare the same 59-end sequence, the predicted full-length
RF would consist of 448 amino acids, which is larger
han the first form. Human CHL (hCHL) cDNAs were
lso isolated, and all of them resembled the longer form
f mCHL. A sequence analysis indicated that there were
mall deletions at two sites within the coding region,
hich would make four different hCHL products (Fig.
B). The longest encoded a protein of 452 amino acids and
as designated hCHL(l1). The suffix “l” in parentheses
tands for the long form, and “1” stands for no deletion.
t one site, one amino acid, E95, was missing, which gave
ise to a 451-amino-acid protein (hCHL(l2)). At the other
ite, a 15-bp segment encoding G319-K-K-A-K323 was miss-
ing, which resulted in a 447-amino-acid protein
(hCHL(l3)). A double mutant was also obtained
(hCHL(l4)). The suffix “2” means the deletion of E95(E96 in
mice), “3” stands for the deletion of the GKKAK stretch,
and “4” corresponds to mutations at both sites. There-
fore, the original mouse clone was renamed mCHL(s2), in p
Copyright © 2001 by Academic Press. All righthich the suffix “s” in parentheses stands for the short
orm, and the second mouse clone was designated
CHL(l3). CHL(l) and CHL(s) represent the long forms
nd the short forms, respectively. The mouse chordin
FIG. 3. MCHL(s2) protein. (A) FLAG-tagged CHL(s2) protein purifi-
cation. The proteins in the peak eluate from anti-FLAG affinity
column chromatography (12 mg/ml mCHL(s2)-FLAG determined by
Western) were separated by SDS–polyacrylamide gel electrophoresis
under reducing conditions and were stained with Coomassie brilliant
blue (Sambrook et al., 1989). The arrow indicates the mCHL(s2)-
FLAG protein band. This band was excised, and the NH2-terminal
amino acid sequence of the extracted peptide was determined (the
vertical arrow in Fig. 1B) to confirm the identity of the band. (B)
Western blot analysis of the purified mCHD-FLAG protein (lane 1)
and mCHL(s2)-FLAG protein (lane 2). The purified FLAG-tag proteins
were visualized with M2 (aFLAG). The arrows indicate the intact
CHL(s2)-FLAG (top) as well as the COOH-terminal portion of the
egradation product (lower duplex). (C) Stability of the mCHL(s2)
rotein. The stable 293 clone for mCHL(s2)-FLAG was plated at 1 3
06 cells/well in a 6-well plate. Twenty-four hours later, the medium
as changed to 2 ml each of 293 SFM II (lane 2), DMEM (lane 3), or
MEM with transferrin and insulin (lane 4), and the cultures were
ncubated further for 48 h. Transient transfection of 293T cells was
lso performed with pSRahEPO (lane 6) and pSRamCHL(s2) (lane 7),
nd 48-h conditioned media were made with DMEM. All of the
ulture supernatants were equally concentrated and 40 ml of each was
ubjected to Western blot analysis with the anti-mCHL antibody
aNH2-mCHL). Lanes 1 and 5 are the purified mCHL(s2)-FLAG
roteins. The arrows indicate the intact size of the mCHL(s2) protein
top) as well as the NH2-terminal portion of the degradation product
bottom).rotein consists of four CRs and is approximately 2 to 2.8
s of reproduction in any form reserved.
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378 Nakayama et al.times larger than the mCHL proteins (945 amino acids),
as illustrated in Fig. 1A. The CR1 and CR3 of mCHL were
most similar to the CR3 of mouse chordin (indicated by
FIG. 4. Direct interaction of mCHL(s2) with BMPs and inhibi-
tion of BMP4 binding to the receptor by mCHL(s2). (A)
Immunoprecipitation/Western blot analysis under low concen-
tration conditions (see Materials and Methods). MCHL(s2)-FLAG
(CHL) and mCHD-FLAG (CHD) were individually mixed with 90 ng
of BMP4, 90 ng of BMP5, 0.1 mg of BMP6, or 0.1 mg of activin A and
were treated with 1.7 and 3.4 mg of the affinity-purified anti-mCHL
(aCHL) and anti-mouse chordin (aCHD) antibodies, respectively. The
resulting immunocomplex was precipitated with protein A agarose
beads. The lane “S” stands for the standard, on which 20 ng of BMP4,
20 ng of BMP5, 10 ng of BMP6, or 20 ng of activin A was loaded
directly. B/A stands for BMP or activin A. (B) Immunoprecipitation/
Western blot analysis under the high concentration conditions (see
Materials and Methods). Both the mCHL/CHD-FLAG protein and the
BMP/activin/TGFb protein were mixed at a higher concentration.
Then, the immunocomplex was formed with anti-mCHL antiserum
(aCHL) or anti-mouse chordin antiserum (aCHD) and was precipi-
ated with protein A/G beads. For the standard (S), 40 ng each of
GFb2, activin A, and BMP5 was loaded directly. A/T stands for
ctivin A or TGFb2. (C) Inhibition of BMP4 binding to BMPR1B by
CHL. (Top panel) mCHL(s2)-FLAG (CHL) was first mixed with BMP4
at various concentrations, as indicated (0.1–1 mg), and then
MPR1BFc was added. The resulting BMPR complex was precipi-
ated, and the bound BMP4 was visualized. (Bottom panel) Binding
pecificity of BMP4 to the BMPR1B extracellular domain was con-
rmed. Note that BMP4 was not coprecipitated with human IgG Fc.
or the standard (S), 20 ng of BMP4 was loaded directly.black boxes).
Copyright © 2001 by Academic Press. All rightThe cloning frequency of the different forms of hCHL was
ot random. For instance, five of five clones isolated from
he prostate cDNA library were either hCHL(l3) or
CHL(l4). However, the PCR–based cloning of hCHL from
uman brain, heart, and prostate cDNAs followed by DNA
equencing revealed that all forms were found in all three
issues (data not shown). Therefore, no tissue-specific ex-
ression of any form has been demonstrated. So far, no
CHL cDNA equivalent to mCHL(s2) has been identified,
nd no mouse equivalents of hCHL(l1), hCHL(l2), and
CHL(l4) have been cloned.
Both Mouse and Human CHL Genes Are Located
on the X Chromosome
A partial sequence of the hCHL gene was found in
GenBank (Accession No. AL049176). The sequence is de-
rived from the q22.1-23 region of the human X chromo-
some, and it was found to contain a region from exon 3 to
exon 12 of the hCHL gene. The mCHL gene was mapped by
FISH using a BAC clone DNA with a chromosomal DNA
segment containing CHL exons as a probe. The mCHL gene
was located at a position 89% of the distance from the
heterochromatic–euchromatic boundary to the telomere of
the X chromosome, which corresponds to band XF3. There-
fore, both the human and mouse CHL genes are located on
the X chromosome.
The Multiple Forms of the CHL cDNAs Were
Probably Created by Alternative Splicing and
Alternative Transcriptional Termination
It was evident from the AL049176 genomic DNA se-
quence that hCHL(l2) could be formed by the use of an
alternative splice acceptor for intron 4 and that hCHL(l3)
was likely to be generated by the use of an alternative splice
donor for intron 9 (Fig. 1C). The mCHL(s2) protein ended 10
amino acids (GALAGGPAFG) after the GKKAK sequence
(Fig. 1B). It was found from the human genomic sequence
that an almost identical amino acid stretch, GALVGG-
PAFG, could be added after GKKAK if no splicing of intron
9 occurred. This would also result in an almost identical
size as the mCHL(s2) protein (333 and 332 amino acids for
hCHL(s1) and for hCHL(s2), respectively). The 39-UTR of
the mCHL(s2) cDNA was homologous to intron 9 of the
hCHL gene, but not to the hCHL(l) 39-UTR in exon 12 (data
not shown). These observations suggest that the CHL(s)
cDNAs were probably derived from the CHL transcripts
that prematurely terminated within intron 9 or from the
splice variants retaining intron 9. On the other hand, the
39-UTR of the mCHL(l3) cDNA was homologous to the
hCHL(l) 39-UTR, suggesting that the mCHL(l3) transcript
stops at a similar site as the hCHL(l) transcripts. Thus, the
CHL variants were probably generated by alternative splic-
ing and/or alternative transcriptional termination.
s of reproduction in any form reserved.
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379A Novel Chordin-like Protein Inhibitor for BMPsCHL Induced a Secondary Axis in the Xenopus
Embryo: Evidence for in Vivo Interaction
with BMP
Chordin is known to dorsalize the gastrulating Xenopus
embryo by inhibiting the activity of BMP4. Therefore, the
effects of the CHLs on Xenopus embryo development were
examined (Fig. 2 and Table 1). When 10–30 pg RNA was
injected per blastomere, the axis duplication rates for
mCHL(s2) and for mCHL(s2)-FLAG ranged from 79 to 87%,
whereas the rate for the uninjected control embryos and the
EF1 RNA-injected embryos was 0% (Table 1). As a positive
control, experiments were also performed with the mCHD-
FLAG RNA, and an axis duplication rate similar to that of
mCHL(s2) was obtained (Table 1). Thus, mCHL(s2), with or
without a FLAG tag at the COOH terminus, was active in
antagonizing the endogenous ventralizing factor (presum-
ably BMP4). The hCHL constructs, including long forms (l1
and l2) and short forms (s1 and s2), displayed essentially the
same effect as mCHL(s2), although the maximum tolerable
amount of RNA (1 ng) was required. This result indicates
that all forms of CHL tested were active in antagonizing the
Xenopus ventralizing factor and suggests that the mouse
HL seemed to be more active in Xenopus embryos than
FIG. 5. Inhibitory effects of mCHL(s2) and mouse chordin protein
on the generation of the CD341CD31hi lymphohematopoietic prog
ell fraction (R2), and the CD451 myelomonocytic cell fraction (R
actor), with BMP4 (BMP4), with BMP410.4 mg/ml mCHL(s2
BMP41CHD) were harvested and analyzed for CD34, CD31, and C
B) Dose-dependent inhibition of the BMP4-dependent generation o
in the presence of BMP4 and various concentrations of mCHL(s2)-
(R11R2) were individually normalized in each experiment so that 1
CHL-FLAG and mCHD-FLAG. Values obtained from two to thre
oncentration of mCHL(s2)-FLAG (h) and mCHD-FLAG protein (ethe human CHLs. a
Copyright © 2001 by Academic Press. All rightThe mCHL(s2) Protein Is Potentially Cleaved
between CR2 and CR3
Further protein analyses were carried out with mCHL(s2).
As shown in Figs. 3A and 3B, a single step of affinity
purification resulted in FLAG-tagged proteins of the ex-
pected sizes (the apparent size of mCHL(s2) was approxi-
mately 38 kD). During the purification, it was noticed that
the expression levels as well as the integrity of mCHL(s2)-
FLAG in serum-free conditioned media depended entirely
on the type of medium used. For instance, DMEM with or
without insulin and transferrin yielded only a very low
level of the protein, which was mostly degraded (Fig. 3C).
Other media, such as s-MEM and IMDM, also gave similar
results (data not shown). The degradation product that
cross-reacted with the anti-NH2-terminal peptide antibody
as approximately 28 kDa in size (Fig. 3C), and those that
ross-reacted with the anti-FLAG antibody were 14 to 16
Da (Fig. 3B). Based on the sizes of these degradation
roducts, the predicted degradation sites were mapped
etween CR2 and CR3. In contrast, 293 SFM II protected
he mCHL(s2)-FLAG protein from degradation and gave
easonable expression levels. Nevertheless, the CHL pro-
ein seemed to be unstable and susceptible to protease
the BMP4-dependent differentiation of ES cells in vitro. (A) Effects
or cell fraction (R1), the CD341CD31lo erythromyeloid progenitor
ven-day-old embryoid bodies (EBs) generated without a factor (No
AG (BMP41CHL), and with BMP410.5 mg/ml mCHD-FLAG
protein expression. Numbers indicate percentages of total EB cells.
CD341 CD311 progenitor cell fraction. ES cells were differentiated
or mCHD-FLAG protein. The CD341CD311 EB cell populations
corresponds to the CD341CD311 EB cell fraction obtained without
ependent experiments were averaged and plotted according to the
ded. The vertical bars are the standard deviation.s on
enit
3). Se
)-FL
D45
f the
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00%
e indttack.
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380 Nakayama et al.Direct Interaction of mCHL(s2) with BMPs and
Inhibition of BMP Binding to the Receptor
by mCHL(s2)
The direct interaction of the Xenopus chordin protein
with human BMP4 has been demonstrated (Piccolo et al.,
1996). Similar experiments were performed using the
mouse chordin and mouse CHL proteins. As shown in Figs.
4A and 4B, both the mCHD-FLAG and mCHL(s2)-FLAG
proteins co-immunoprecipitated with BMP4, BMP5, and
BMP6. However, under the low concentration condition
(Fig. 4A), BMP5 showed no sign of interaction with
mCHL(s2)-FLAG and a very weak interaction with mCHD-
FLAG. On the other hand, BMP6 gave significantly weaker
signals for both proteins compared with the high concen-
tration condition. These observations suggest that both
chordin and CHL might have weaker affinities with BMP5
and BMP6 than with BMP4. Activin A, another TGFb
superfamily member, showed no sign of interaction with
chordin and CHL under either set of conditions. BMP2 and
BMP4 form a separate subfamily from BMP5, BMP6, and
BMP7 (Celeste et al., 1990). Thus, both the chordin and
CHL proteins may be pan-BMP binding proteins. Interest-
ingly, mCHL(s2)-FLAG, but not mCHD-FLAG, interacted
with TGFb1 (data not shown) and TGFb2 (Fig. 4B) under the
igh concentration condition.
Chordin prevents BMP action by inhibiting the interac-
ions of BMPs with their receptors. Therefore, we deter-
ined whether CHL functioned in a similar fashion. The
xtracellular domain of the BMP receptor 1B fused to the Fc
ortion of human IgG (BMPR1BFc) was mixed with BMP4
nd was precipitated with protein A beads. As shown in Fig.
C, without the mCHL(s2)-FLAG protein, BMP4 was copre-
ipitated with BMPR1BFc but not with Fc, indicating that
MP4 bound specifically to the BMPR1B extracellular do-
ain. With increasing amounts of mCHL(s2)-FLAG added,
owever, the BMP4 signal became weaker. At concentra-
ions of 0.5 mg/ml or higher, the reduction was especially
evident. This result suggests that, similar to chordin, CHL
may also prevent BMP4 from binding to the receptor.
MCHL(s2) Inhibits BMP4 Action in Vitro
Complex formation with chordin is known to inhibit
BMP4 function. Judging from the similar axis duplication
activity to chordin, CHL would also inhibit BMP4 action
directly. We have demonstrated previously that the genera-
tion of CD341 CD31hi lymphohematopoietic progenitor
ells, CD341 CD31lo erythromyeloid progenitor cells, and
D451 myelomonocytic cells is dependent on the presence
f 0.15 to 2 ng/ml of BMP4 during the differentiation of
ouse ES cells (Nakayama et al., 2000). A BMP4 concen-
ration of 0.6 ng/ml resulted in an approximately half-
aximal level (data not shown). When affinity-purified
CHL(s2)-FLAG and mCHD-FLAG proteins were each
dded, at 10 to 500 ng/ml per assay, the CD341 CD31hi,
CD341 CD31lo, and CD451 cell populations were signifi-
cantly reduced (Fig. 5A), and this inhibition was dose-
Copyright © 2001 by Academic Press. All rightependent (Fig. 5B). These results suggest that the FLAG-
agged CHL and chordin proteins were each able to inhibit
he action of BMP4 in vitro.
Localization of CHL mRNA Expression
A Northern blot analysis indicated that CHL and chordin
were differentially expressed over time during mouse em-
bryogenesis (Fig. 6A). The E7 mouse embryo as a whole
expressed chordin mRNA but not CHL mRNA, whereas the
pattern was reversed in embryos later than E11. In the adult
mouse (Fig. 6B), distinct patterns of expression were main-
tained. CHL transcripts 4 kb in length were present in
brain, lung, kidney, and testis. However, liver expression
was consistently very low. On the contrary, the chordin
mRNA was detected mainly in the liver and brain. In
humans, the chordin mRNA was detected predominantly
in the liver (data not shown).
It is worth noting that no transcript significantly longer
than 4 kb was observed on the Northern blots. Furthermore,
the specific probe for the mCHL(s) mRNA (intron 9 probe)
detected only transcripts with a similar size (approximately
4 kb) in mouse embryos and adult tissues. The intron 9 of
the human CHL gene is approximately 6.9 kb in length.
Assuming that the intron 9 of the mouse CHL gene has a
similar size, these observations support the idea that the
mCHL(s) mRNA might be generated by premature termi-
nation (Fig. 1C).
CHL mRNA Expression during Skeletogenesis
An in situ hybridization analysis revealed CHL expres-
sion beginning around embryonic day 9.5 and persisting in
a wide range of adult stromal and connective tissue cell
types of mesenchymal origin. No CHL signal was detected
in the sections examined at E8.5. At E9.5, the signal was
just barely detectable over the somites but not the limb bud
(data not shown). At E10.5, strong signals were seen over
the dermatome portion of the somites and diffusely over the
limb bud mesenchyme (Figs. 7A–7D). In the E11.5 limb
(Figs. 7G and 7H) and elsewhere throughout the developing
skeleton (data not shown), the CHL mRNA was present
over areas of mesenchymal cells concurrent with the for-
mation of precartilaginous mesenchymal condensations. At
E12.5, this included the cephalic mesenchyme in areas
where the basioccipital and exoccipital bones form, over
mesenchymal cells in the mandible, and adjacent to the
dorsal root ganglia in areas where vertebrae would form
(data not shown). At E13.5, strong CHL signals were
detectable over the hypertrophic chondrocytes in limb
bones (Figs. 7I and 7J), clavicle, and sternum, as well as in
the perichondrial mesenchymal cells adjacent to the
developing joints. Strong CHL expression continued in
the hypertrophic chondrocytes within the developing
bones (E15.5, Figs. 7E, 7F, 7K, and 7L) and began to
decline in the perichondrial mesenchymal cells, a pattern
that contrasts with that of chordin (Fig. 7M), which was
s of reproduction in any form reserved.
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381A Novel Chordin-like Protein Inhibitor for BMPsstrikingly absent in the cartilage elements. By E18.5 and
through to the adult, the skeletal expression of CHL was
present at diminished levels and was restricted to the
hypertrophic chondrocytes at the epiphyseal growth
plate, scattered cells in the bone marrow, which appeared
to be a population of bone marrow stromal cells (Figs. 7N,
7O, 8A, and 8B), and at barely detectable levels in the
articular chondrocytes at the joint surfaces.
Nonskeletal Expression of CHL
CHL was also expressed in a range of nonskeletal mesen-
chymal cell types. Expressions in subdermal fusiform stro-
mal cells, connective tissue cells of the epimysium and
perimysium surrounding bundles of skeletal muscle, a layer
of fibroblast/connective tissue cells dividing the submucosa
and muscularis of the gastrointestinal tract (Figs 8C and
8D), and perivascular cells were all detectable embryoni-
cally and persisted into adulthood. A strong and striking
pattern of adult CHL expression was present in the outer
medulla and medullary rays of the kidney (Fig. 8E). The
CHL-positive cells formed segments of proximal and distal
tubules, derived from the nephrogenic mesenchyme (Fig.
8F). Additional sites of adult CHL expression included
trabecular connective tissue cells in the lymph nodes,
perivascular cells in the lung, myofibroblasts in the uterus,
and stromal cells in white adipose tissue (data not shown).
In addition to these mesenchymal cell types, the signal
was detected at E10.5 in the differentiating fields of the
ventral telencephalon and the dorsal rhombencephalon,
which are destined to become the olfactory bulb and the
cerebellum, respectively. Other parts of the developing
nervous system lacked CHL expression. The CHL expres-
sion in these regions persisted through embryonic develop-
ment, and adult cerebellar Purkinje cells (Figs. 8G and 8H),
olfactory bulb neurons, and cerebral cortical neurons (and
glia-like cells) continued to express CHL.
Thus, the CHL gene was expressed preferentially in cell
types originating from the embryonic mesenchyme. The
only nonmesenchymal cell lineage expressing the CHL
mRNA was the neuron.
FIG. 7. CHL mRNA expression during embryogenesis. In situ hybri
left) and darkfield (right) panels. (A, B) Sagittal section through an E10
n the limb bud. (C, D) Higher magnification of the boxed area in A sh
) Transverse section through the thoracic region at E15.5. Arrowhead
eural arch, radius, metacarpal, and phalangeal bones. The signal is a
ones and in subcutaneous stromal cells. (G–O) Higher magnifica
rrowheads indicate CHL-positive hypertrophic chondrocytes in the
s present over areas of mesenchymal cells as precartilaginous mese
etectable over the hypertrophic chondrocytes in the radius (arrowhe
rist joints. (K, L) At E15.5, CHL expression in the limb is most notab
halanges (arrowheads). (M) In situ hybridization with a chordin pro
hordin expression in cartilage elements. (N, O) At E18.5, CHL expre
rowth plates. Abbreviations used: lb, limb bud; h, heart; hu, humeru
, digit; li, liver; lu, lung. Scale bars are indicated on the brightfield panels
Copyright © 2001 by Academic Press. All rightFIG. 6. Differential expression of the CHL gene and the chordin
gene. Northern blot analyses were performed using Clontech
blots. The blots were first probed with a DNA containing the
mCHL(s2) ORF (CHL) and then were reprobed with the mouse
chordin cDNA (CHD) and finally with the human b-actin
ragment (b-actin). Three different batches of blots were
sed. All gave essentially the same results. A separate batch
f RNA blot was probed with the intron 9 probe to detect
he mCHL(s)-specific transcript (CHL(s)). The pattern of expres-
ion of the b-actin mRNA (not shown) was indistinguishable
from that shown here. (A) Mouse embryo blot made with E7
(7), E11 (11), E15 (15), and E17 (17) embryo-derived RNA.
(B) Mouse adult tissue blot made with heart (H), brain (B), spleen
(S), lung (Lu), liver (Li), skeletal muscle (M), kidney (K), anddization for CHL in normal mouse embryos, depicted in paired brightfield
.5 mouse demonstrates CHL expression in the somites and a diffuse signal
ows the CHL signal in the dermatome portion of the somites at E10.5. (E,
s indicate the expression of CHL in the hypertrophic chondrocytes in the
lso present in areas of condensed mesenchyme adjacent to the developing
tion views of the forelimb of E11.5, E13.5, E15.5, and E18.5 embryos.
growth plate regions of the developing radius. (G, H) At E11.5, the signal
nchymal condensations begin to form. (I, J) At E13.5, CHL expression is
ad) and in the perichondrial mesenchymal cells adjacent to the elbow and
le in the hypertrophic chondrocytes of the radius, tarsals, metatarsals, and
be in an E15.5 section adjacent to K demonstrates a conspicuous lack of
ssion in bone is restricted to hypertrophic chondrocytes at the epiphyseal
s; ra, radius; eso, esophagus; sp, spinal cord; na, neural arch; gut, intestine;.
s of reproduction in any form reserved.
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383A Novel Chordin-like Protein Inhibitor for BMPsFIG. 8. Expression of CHL mRNA in adult mouse tissues. In situ hybridization for CHL in normal adult mouse tissue. (A) Longitudinal section
through the epiphyseal growth plate region of the adult femur. Arrowheads indicate expression of CHL mRNA in hypertrophic chondrocytes. (B)
CHL-positive cells in the bone marrow (arrowheads) appear to be a population of bone marrow stromal cells. (C, D) Paired bright- and darkfield
images of a cross section through the duodenum, showing CHL mRNA expression in a layer of stromal/connective tissue cells between the
submucosa and muscularis. (E, F) Transverse section through a normal adult mouse kidney, showing expression of CHL mRNA primarily in the
region of the outer medulla and medullary rays. The boxed area in E is shown at a higher magnification in F, where the signal appears to be
localized in segments of the thick ascending tubules (arrowheads). (G, H) CHL mRNA is expressed in the Purkinje cell layer of the cerebellum.
Abbreviations used: muc, submucosa; mus, muscularis; cx, cortex; m, medulla; p, papilla; gl, granule cells; wm, white matter; pl, Purkinje cell
layer; ml, molecular layer. Scale bars are indicated.
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384 Nakayama et al.DISCUSSION
We have demonstrated that a novel X-linked chordin-like
gene, CHL, encodes a protein that directly interacts with
BMPs and inhibits their actions in vitro as well as in vivo.
he expression analysis suggests a possible role of CHL
uring skeletogenesis as well as in several other organo-
enic processes. This is the first demonstration that a
hordin-type BMP inhibitor forms a gene family in mam-
als.
Structure and Function of CHL
Based on the Gap analysis (Genetics Computer Group),
the overall amino acid sequence similarity between the
mouse chordin and mCHL(s2) was 28%, and the nucleic
acid homology of the ORF was 37%. Only the CR units
showed statistically significant homology. Therefore, the
sequence homology was not sufficient to imply functional
similarities between chordin and CHL. However, when
injected into early Xenopus embryos, the CHL RNA
showed a clear axis duplication activity similar to that of
mouse chordin RNA (Fig. 2). In fact, recombinant
mCHL(s2) protein and mouse chordin protein were able to
interact directly with the three BMPs tested (Fig. 4). Both
proteins also inhibited BMP function in vitro when added to
the serum-free differentiation culture of ES cells, which
leads to the generation of lymphohematopoietic progenitor
cells in a BMP4-dependent manner (Fig. 5 and Nakayama et
al., 2000). Furthermore, the inhibition of BMP action by the
mCHL(s2) protein seemed to be achieved by preventing
BMP4 from interacting with the BMP receptor (Fig. 4C).
These results suggest that CHL is not only structurally
related to but also functionally similar to chordin.
One difference in the activities of CHL and chordin was
the target specificity. MCHL(s2) showed weak but suffi-
cient binding capability to be coprecipitated with TGFb1
data not shown) and TGFb2 (Fig. 4B) when the high
concentration conditions were used. In contrast, mouse
chordin did not show any sign of interaction with them,
consistent with the properties of Xenopus chordin (Piccolo
et al., 1996). However, we still have not succeeded in
determining whether the interaction with CHL inhibits
TGFb function.
CHL was present in multiple forms in both mouse and
uman (Fig. 1). As in the case of chordin, these variations
ould change some of the CHL activities (Yu et al., 2000).
owever, given that the two long forms, l1 and l2, and the
wo short forms, s1 and s2, induced a secondary axis in the
enopus embryo (Table 1), all forms are likely to share the
MP-antagonizing activity. Interestingly, all of the varia-
ions are located outside the CRs: E95/96 directly follows
CR1, the GKKAK is immediately after CR3, and the short
form contains an altered COOH-terminal sequence after
the GKKAK (Fig. 1B). Since the CRs are the binding sites for
BMPs (Larrain et al., 2000), these variations may not affect
the CHL’s binding specificity to BMPs. On the other hand,
Copyright © 2001 by Academic Press. All righthey may affect the stability and/or integrity of the protein.
n this regard, it is worth noting that the axis duplication
ates obtained with the long forms of hCHL fluctuated
ignificantly, even when 1 ng of RNA was injected per
lastomere, while the short forms of hCHL gave more
onsistent and higher values, suggesting that the short
orms might be more stable and/or active than the long
orms of CHL.
The mCHL(s2) protein was unstable and readily degraded
n conditioned media (Fig. 3C). This was also the case for
he hCHL(l1) protein (data not shown). Therefore, CHL
rotein instability does not seem to be specific for either the
ouse protein or the short form. It is known that BMP1/
olloid inactivates chordin (Piccolo et al., 1997; Scott et al.,
1999). Interestingly, CHL contained potential BMP1 target
sites between CR2 and CR3, the area consistent with our
estimated degradation sites (Fig. 1). Therefore, CHL could
be under the BMP1-dependent control mechanism. There
were also several potential cleavage sites (K/R-(X)n-K/R,
n 5 0, 2, 4, or 6) for proprotein convertase between CR2 and
R3 (reviewed in Seidah and Chretien, 1999). Therefore,
hat appeared to be degradation products could be mature
orms of CHL. These degraded/processed products of CHL
ay show very weak inhibitory activity (Larrain et al.,
000) and/or possess altered target specificity (Yu et al.,
000), as in the case of chordin. Supporting the former, the
CHL(s2) preparation, made through transient transfection
f 293T cells, which was mostly composed of degraded/
rocessed products (Fig. 3C), was not active in suppressing
MP4 activity during ES cell differentiation (data not
hown). Thus, if the degraded/processed forms are the
unctional forms in vivo, then the biological role of CHL
ould be agonistic instead of antagonistic to BMP action.
Further biochemical characterizations of CHL as well as
he CHL variants and genetic analysis of the CHL gene
ould provide definitive answers to these questions.
Biological Implications of CHL
The CHL transcript was first detected in the somites of
the E9.5 mouse embryo, and at E10.5, strong signals were
observed in the dermatome and limb bud mesenchymes
(Figs. 7A–7D). Consistently, the developing skeletal struc-
ture, including limb bones, clavicle, calvaria, vertebra, and
rib (ex. at E15.5, Figs. 7E and 7F), was one of the major CHL
expression sites during embryogenesis. During the limb
bone formation, the CHL expression was first detected in
the precartilaginous mesenchymal condensation of the
limb bud (Figs. 7G and 7H) and later was restricted to the
hypertrophic chondrocytes in the epiphyseal growth re-
gions, and its expression levels progressively diminished as
the embryo developed (Figs. 7I–7O and 8A). On the con-
trary, the chordin-expressing sites in the forelimb did not
overlap with the CHL-expressing areas (they were like a
mirror image), suggesting that chordin and CHL would have
different and/or non-overlapping biological roles during
limb formation (Figs. 7K–7M). This observation supports
s of reproduction in any form reserved.
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385A Novel Chordin-like Protein Inhibitor for BMPsthe previous finding that in the E15.5 hindlimb, the chordin
transcript is detected throughout the limb mesenchyme,
with particularly high levels of expression overlying the
perichondrium of the ossifying cartilage of the femur as
well as that of the cartilage primordia of the tarsals,
metatarsals, and phalanges (Scott et al., 1999, 2000). Simi-
larly, Gremlin, another BMP binding inhibitor family, is
expressed in the nonchondrogenic region of the limb bud
and later in the interdigital mesenchyme and the differen-
tiating perichondrium (Merino et al., 1999). However, the
xpression sites of the CHL mRNA in the developing limb
verlapped somewhat with those of noggin mRNA, includ-
ng the mesenchymal condensations in the limb bud and
he chondrocytes of the developing limb bone (Brunet et al.,
998; Capdevila and Johnson, 1998; Merino et al., 1998;
ifuji and Noda, 1999; Pathi et al., 1999). Nevertheless,
ince BMPs are expressed in the limb cartilage, the ster-
um, and the rib during mouse embryogenesis (Solloway et
l., 1998; and reviewed in Wozney et al., 1993) and are
mplicated in many stages of bone formation (reviewed in
arsenty, 1998), these results support the hypothesis that
HL may participate in regulating BMP action during
keletogenesis, and the biological role of CHL may be
hared in part by noggin.
On the other hand, the expression of CHL mRNA in
onskeletal mesenchymal cells in the embryo, such as
ubdermal mesenchymes and gut mesenchymes (Figs. 7E
nd 7F), seemed to continue into many adult connective
issue cell types. For example, in the stomach, the intestine,
nd the colon, the expression was localized specifically on a
ayer of fibroblasts/connective tissue cells that divided the
ubmucosa and muscularis (Figs. 8C and 8D). In contrast,
he chordin signal was detected weakly over the connective
issue cells in the muscularis of the gastrointestinal tract
nd was never restricted to a single layer (data not shown).
uring the gastrointestinal development of the chicken,
MP4 is induced in the non-smooth muscle mesenchyme
round the endodermal epithelium, which later differenti-
tes into the submucosa, and inhibits the differentiation of
mooth muscle and enteric neurons in the muscularis
Smith et al., 2000; Sukegawa et al., 2000). In this respect,
he layer of CHL-expressing cells may serve as a wall that
revents the migration of active BMPs into the muscularis.
urthermore, the strong CHL signal in the tubules of the
idney outer medulla (Figs. 8E and 8F) suggests that CHL
ay also be involved in mesenchymal cell differentiation
uring nephrogenesis, especially because BMP is required
or the nephrogenic mesenchyme to grow and survive, but
s inhibitory for tubulogenesis (Dudley et al., 1999). In
ontrast, the chordin signal was observed only in a layer of
onnective tissue/fibroblast-like cells beneath the urothe-
ium lining, the portion of the renal pelvis that connects to
he ureter (data not shown). Thus, CHL and chordin are also
ifferentially expressed in the kidney.
CHL mRNA expression in mesenchymal cell lineages is
onsistent with our isolation of the cDNA from the prea-
ipocytic stromal cell line OP9. In fact, in both the verte-
Copyright © 2001 by Academic Press. All rightrae (data not shown) and the adult femur (Fig. 8B), the in
itu hybridization signal was detected over the nonhema-
opoietic cell types in the marrow space. The chordin signal
n the bone marrow was too weak to detect (data not shown).
hether CHL and BMPs have any role in hematopoiesis
emains to be determined. In this respect, it is worth mention-
ng that the CHL mRNA expression in bone marrow stromal
ell lines has some correlation with their ability to support
ong-term in vitro hematopoiesis (data not shown).
The expression of CHL in restricted areas of the develop-
ng brain suggests a possible role of CHL in the regulation of
MP activity during the generation of specific neurons:
lfactory bulb neurons and Purkinje cells. Supporting this
ypothesis, BMPs are expressed on the Purkinje cell layer
Nakashima et al., 1999; Zhao et al., 1999), and the involve-
ent of BMPs in cerebellar granule neuron genesis has been
emonstrated recently (Alder et al., 1999). Interestingly,
here were also differences between the expression domains
f chordin and those of CHL in the adult brain. For instance,
strong chordin signal was detected over the hippocampus
including the dentate gyrus), where the CHL signal was
bsent (N. Nakayama, unpublished results; Scott et al.,
000). Furthermore, in the cerebellum, the chordin tran-
cript was detected over granule cells, but not on Purkinje
ells (N. Nakayama, unpublished results; Scott et al., 2000).
In conclusion, a large body of evidence has suggested that
he function of BMP is regulated by a variety of binding
roteins in the extracellular space. In this respect, the
dentification of CHL provides additional support for the
dea that this regulatory mechanism is widely employed for
MPs and that individual BMP binding proteins are respon-
ible for eliciting the distinct biological roles of the BMPs.
ome questions remain: does CHL play an indispensable
ole at any of the expression sites and is the spatiotemporal
ontrol of CHL gene expression critical? However, the
esults that CHL inhibited BMP action, that the main and
nitial expression sites during embryogenesis were the
eveloping skeleton, and that it was differentially expressed
rom chordin in many areas have prompted us to speculate
hat there may be a biological process in which CHL plays
n essential role and that it would include skeletogenesis.
hus, the present demonstration may also provide further
nsights into how BMP actions are regulated spatially and
emporarily during organogenesis.
ACKNOWLEDGMENTS
First we acknowledge the scientists and the technicians in the
Genomics groups and the Department of Computational Biology
for constructing the nucleotide sequence databases and for help
with their analysis. We also acknowledge the Amgen CORPS group
for coordinating the middle-scale CHL protein purification. We
greatly appreciate the contributions of J. Hui and M. Haniu in
determining the NH2-terminal amino acid sequences of the mature
CHL and chordin proteins. Finally, we give warm thanks to S.
Wooden for providing plasmids, to J. Li, S. Simonet, and W. Boyle
for sharing information and interesting discussions, to S. Simonet
s of reproduction in any form reserved.
AA
B
B
386 Nakayama et al.for critical reading of the manuscript, and to S. Simonet and W.
Boyle for support and encouragement. R.N. and T.Y. are supported
by Japan Amgen, K.K.
REFERENCES
Adams, M. D., Kelley, J. M., Gocayne, J. D., Dubnick, M., Poly-
meropoulos, M. H., Xiao, H., Merril, C. R., Wu, A., Olde, B.,
Moreno, R. F., Kerlavage, A. R., McCombie, W. R., and Venter,
J. C. (1991). Complementary DNA sequencing: Expressed se-
quence tags and human genome project. Science 252, 1651–1656.
dra, C. N., Boer, P. H., and McBurney, M. W. (1987). Cloning and
expression of the mouse pgk-1 gene and the nucleotide sequence
of its promoter. Gene 60, 65–74.
lder, J., Lee, K. J., Jessell, T. M., and Hatten, M. E. (1999).
Generation of cerebellar granule neurons in vivo by transplanta-
tion of BMP-treated neural progenitor cells. Nat. Neurosci. 2,
535–540.
achiller, D., Klingensmith, J., Kemp, C., Belo, J. A., Anderson,
R. M., May, S. R., McMahon, J. A., McMahon, A. P., Harland,
R. M., Rossant, J., and De Robertis, E. M. (2000). The organizer
factors Chordin and Noggin are required for mouse forebrain
development. Nature 403, 658–661.
elo, J. A., Bouwmeester, T., Leyns, L., Kertesz, N., Gallo, M.,
Follettie, M., and De Robertis, E. M. (1997). Cerberus-like is a
secreted factor with neutralizing activity expressed in the ante-
rior primitive endoderm of the mouse gastrula. Mech. Dev. 68,
45–57.
Biben, C., Stanley, E., Fabri, L., Kotecha, S., Rhinn, M., Drinkwater,
C., Lah, M., Wang, C. C., Nash, A., Hilton, D., Ang, S. L., Mohun,
T., and Harvey, R. P. (1998). Murine cerberus homologue
mCer-1: A candidate anterior patterning molecule. Dev. Biol.
194, 135–151. doi: 10.1006/dbio/1997.8812.
Bouwmeester, T., Kim, S., Sasai, Y., Lu, B., and De Robertis, E. M.
(1996). Cerberus is a head-inducing secreted factor expressed in
the anterior endoderm of Spemann’s organizer. Nature 382,
595–601.
Brunet, L. J., McMahon, J. A., McMahon, A. P., and Harland, R. M.
(1998). Noggin, cartilage morphogenesis, and joint formation in
the mammalian skeleton. Science 280, 1455–1457.
Capdevila, J., and Johnson, R. L. (1998). Endogenous and ectopic
expression of noggin suggests a conserved mechanism for regu-
lation of BMP function during limb and somite patterning. Dev.
Biol. 197, 205–217. doi: 10.1006/dbio/1997.8824.
Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen,
V., Wang, E. A., and Wozney, J. M. (1990). Identification of
transforming growth factor beta family members present in
bone-inductive protein purified from bovine bone. Proc. Natl.
Acad. Sci. USA 87, 9843–9847.
Dale, L., and Wardle, F. C. (1999). A gradient of BMP activity
specifies dorsal-ventral fates in early Xenopus embryos. Semin.
Cell Dev. Biol. 10, 319–326. doi: 10.1006/scdb/1999.0308.
Dudley, A. T., Godin, R. E., and Robertson, E. J. (1999). Interaction
between FGF and BMP signaling pathways regulates develop-
ment of metanephric mesenchyme. Genes Dev. 13, 1601–1613.
Francois, V., Solloway, M., O’Neill, J. W., Emery, J., and Bier, E.
(1994). Dorsal-ventral patterning of the Drosophila embryo de-
pends on a putative negative growth factor encoded by the short
gastrulation gene. Genes Dev. 8, 2602–2616.
Fuerthauer, M., Thisse, B., and Thisse, C. (1999). Three different
noggin genes antagonize the activity of bone morphogenetic
Copyright © 2001 by Academic Press. All rightproteins in the zebrafish embryo. Dev. Biol. 214, 181–196. doi:
10.1006/dbio/1999.9401.
Harland, R., and Gerhart, J. (1997). Formation and function of
Spemann’s organizer. Annu. Rev. Cell Dev. Biol. 13, 611–667.
Harlow, E., and Lane, D. (1988). “Antibodies: A Laboratory
Manual.” Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY.
Hogan, B. L. (1996). Bone morphogenetic proteins: Multifunctional
regulators of vertebrate development. Genes Dev. 10, 1580–
1594.
Hsu, D. R., Economides, A. N., Wang, X., Eimon, P. M., and
Harland, R. M. (1998). The Xenopus dorsalizing factor Gremlin
identifies a novel family of secreted proteins that antagonize
BMP activities. Mol. Cell 1, 673–683.
Jacobs, K. A., Collins-Racie, L. A., Colbert, M., Duckett, M.,
Golden-Fleet, M., Kelleher, K., Kriz, R., LaVallie, E. R., Merberg,
D., Spaulding, V., Stover, J., Williamson, M. J., and McCoy, J. M.
(1997). A genetic selection for isolating cDNAs encoding secreted
proteins. Gene 198, 289–296.
Karsenty, G. (1998). Genetics of skeletogenesis. Dev. Genet. 22,
301–313.
Klein, R. D., Gu, Q., Goddard, A., and Rosenthal, A. (1996).
Selection for genes encoding secreted proteins and receptors.
Proc. Natl. Acad. Sci. USA 93, 7108–7113.
Larrain, J., Bachiller, D., Lu, B., Agius, E., Piccolo, S., and De
Robertis, E. M. (2000). BMP-binding modules in chordin: A
model for signalling regulation in the extracellular space. Devel-
opment 127, 821–830.
Lemaire, P., Garrett, N., and Gurdon, J. B. (1995). Expression
cloning of Siamois, a Xenopus homeobox gene expressed in
dorsal-vegetal cells of blastulae and able to induce a complete
secondary axis. Cell 81, 85–94.
Matsui, M., Mizusek, K., Nakatani, J., Nakanishi, S., and Sasai, Y.
(2000). Xenopus kielin: A dorsalizing factor containing multiple
chordin-type repeats secreted from the embryonic midline. Proc.
Natl. Acad. Sci. USA 97, 5291–5296.
McMahon, J. A., Takada, S., Zimmerman, L. B., Fan, C. M.,
Harland, R. M., and McMahon, A. P. (1998). Noggin-mediated
antagonism of BMP signaling is required for growth and pattern-
ing of the neural tube and somite. Genes Dev. 12, 1438–1452.
Merino, R., Ganan, Y., Macias, D., Economides, A. N., Sampath,
K. T., and Hurle, J. M. (1998). Morphogenesis of digits in the
avian limb is controlled by FGFs, TGFbetas, and noggin through
BMP signaling. Dev. Biol. 200, 35–45. doi: 10.1006/dbio/
1998.8946.
Merino, R., Rodriguez-Leon, J., Macias, D., Ganan, Y., Economides,
A. N., and Hurle, J. M. (1999). The BMP antagonist Gremlin
regulates outgrowth, chondrogenesis and programmed cell death
in the developing limb. Development 126, 5515–5522.
Nakashima, M., Toyono, T., Akamine, A., and Joyner, A. (1999).
Expression of growth/differentiation factor 11, a new member of
the BMP/TGFbeta superfamily during mouse embryogenesis.
Mech. Dev. 80, 185–189.
Nakayama, N., Fang, I., and Elliott, G. (1998). Natural killer and
B-lymphoid potential in CD341 cells derived from embryonic
stem cells differentiated in the presence of vascular endothelial
growth factor. Blood 91, 2283–2295.
Nakayama, N., Lee, J., and Chiu, L. (2000). Vascular endothelial
growth factor synergistically enhances bone morphogenetic
protein-4-dependent lymphohematopoietic cell generation from
embryonic stem cells in vitro. Blood 95, 2275–2283.
s of reproduction in any form reserved.
NO
P
P
P
P
P
P
S
S
S
S
S
S
S
387A Novel Chordin-like Protein Inhibitor for BMPsNifuji, A., and Noda, M. (1999). Coordinated expression of noggin
and bone morphogenetic proteins (BMPs) during early skeleto-
genesis and induction of noggin expression by BMP-7. J. Bone
Miner. Res. 14, 2057–2066.
ishinakamura, R., Matsumoto, Y., Matsuda, T., Ariizumi, T.,
Heike, T., Asashima, M., and Yokota, T. (1999). Activation of
Stat3 by cytokine receptor gp130 ventralizes Xenopus embryos
independent of BMP-4. Dev. Biol. 216, 481–490. doi: 10.1006/
dbio/1999.9518.
zaki, T., Ma, J., Takenaga, K., and Sakiyama, S. (1996). Cloning of
mouse DAN cDNA and its down-regulation in transformed cells.
Jpn. J. Cancer Res. 87, 58–61.
appano, W. N., Scott, I. C., Clark, T. G., Eddy, R. L., Shows, T. B.,
and Greenspan, D. S. (1998). Coding sequence and expression
patterns of mouse chordin and mapping of the cognate mouse
chrd and human CHRD genes. Genomics 52, 236–239.
athi, S., Rutenberg, J. B., Johnson, R. L., and Vortkamp, A. (1999).
Interaction of Ihh and BMP/Noggin signaling during cartilage
differentiation. Dev. Biol. 209, 239–253. doi: 10.1006/dbio/
1998.9181.
earce, J. J., Penny, G., and Rossant, J. (1999). A mouse cerberus/
Dan-related gene family. Dev. Biol. 209, 98–110. doi: 10.1006/
dbio/1999.9240.
iccolo, S., Agius, E., Lu, B., Goodman, S., Dale, L., and De
Robertis, E. M. (1997). Cleavage of Chordin by Xolloid metallo-
protease suggests a role for proteolytic processing in the regula-
tion of Spemann organizer activity. Cell 91, 407–416.
iccolo, S., Sasai, Y., Lu, B., and De Robertis, E. M. (1996).
Dorsoventral patterning in Xenopus: Inhibition of ventral signals
by direct binding of chordin to BMP-4. Cell 86, 589–598.
odos, S. D., and Ferguson, E. L. (1999). Morphogen gradients-new
insights from Dpp. Trends Genet. 15, 396–402.
ambrook, J., Fritsch, E. F., and Maniatis, T. (1989). “Molecular
Cloning: A Laboratory Manual.” Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY.
asai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L. K., and De
Robertis, E. M. (1994). Xenopus chordin: A novel dorsalizing
factor activated by organizer-specific homeobox genes. Cell 79,
779–790.
chulte-Merker, S., Lee, K. J., McMahon, A. P., and Hammer-
schmidt, M. (1997). The zebrafish organizer requires chordino.
Nature 387, 862–863.
cott, I. C., Blitz, I. L., Pappano, W. N., Imamura, Y., Clark, T. G.,
Steiglitz, B. M., Thomas, C. L., Maas, S. A., Takahara, K., Cho,
K. W., and Greenspan, D. S. (1999). Mammalian BMP-1/Tolloid-
related metalloproteinases, including novel family member
mammalian Tolloid-like 2, have differential enzymatic activities
and distributions of expression relevant to patterning and skel-
etogenesis. Dev. Biol. 213, 283–300. doi: 10.1006/dbio/
1999.9383.
cott, I. C., Steiglitz, B. M., Clark, T. G., Pappano, W. N., and
Greenspan, D. S. (2000). Spatiotemporal expression patterns of
mammalian chordin during postgastrulation embryogenesis and
in postnatal brain. Dev. Dyn. 217, 449–456.
eidah, N. G., and Chretien, M. (1999). Proprotein and prohormone
convertases: A family of subtilases generating diverse bioactive
polypeptides. Brain Res. 848, 45–62.
hawlot, W., Deng, J. M., and Behringer, R. R. (1998). Expression of
the mouse cerberus-related gene, Cerr1, suggests a role in ante-
Copyright © 2001 by Academic Press. All rightrior neural induction and somitogenesis. Proc. Natl. Acad. Sci.
USA 95, 6198–6203.
Shi, Y.-P., Mohapatra, G., Miller, J., Hanahan, D., Lander, E., Gold,
P., Pinkel, D., and Gray, J. (1997). FISH probes for mouse
chromosome identification. Genomics 45, 42–47.
Smith, D. M., Nielsen, C., Tabin, C. J., and Roberts, D. J. (2000).
Roles of BMP signaling and Nkx2.5 in patterning at the chick
midgut-foregut boundary. Development 127, 3671–3681.
Smith, W. C., and Harland, R. M. (1992). Expression cloning of
noggin, a new dorsalizing factor localized to the Spemann orga-
nizer in Xenopus embryos. Cell 70, 829–840.
Solloway, M. J., Dudley, A. T., Bikoff, E. K., Lyons, K. M., Hogan,
B. L., and Robertson, E. J. (1998). Mice lacking Bmp6 function.
Dev. Genet. 22, 321–339.
Stanley, E., Biben, C., Kotecha, S., Fabri, L., Tajbakhsh, S., Wang,
C. C., Hatzistavrou, T., Roberts, B., Drinkwater, C., Lah, M.,
Buckingham, M., Hilton, D., Nash, A., Mohun, T., and Harvey,
R. P. (1998). DAN is a secreted glycoprotein related to Xenopus
cerberus. Mech. Dev. 77, 173–184.
Sukegawa, A., Narita, T., Kameda, T., Saitoh, K., Nohno, T., Iba,
H., Yasugi, S., and Fukuda, K. (2000). The concentric structure of
the developing gut is regulated by Sonic hedgehog derived from
endodermal epithelium. Development 127, 1971–1980.
Takahashi, N., and Ko, M. S. H. (1994). Toward a whole cDNA
catalog: Construction of an equalized cDNA library from mouse
embryos. Genomics 23, 202–210.
Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K.,
Yoshida, M., and Arai, N. (1988). SR alpha promoter: an efficient
and versatile mammalian cDNA expression system composed of
the simian virus 40 early promoter and the R-U5 segment of
human T-cell leukemia virus type 1 long terminal repeat. Mol.
Cell. Biol. 8, 466–472.
Topol, L. Z., Marx, M., Laugier, D., Bogdanova, N. N., Boubnov,
N. V., Clausen, P. A., Calothy, G., and Blair, D. G. (1997).
Identification of drm, a novel gene whose expression is sup-
pressed in transformed cells and which can inhibit growth of
normal but not transformed cells in culture. Mol. Cell. Biol. 17,
4801–4810.
Wang, E. A. (1993). Bone morphogenetic proteins (BMPs): Thera-
peutic potential in healing bony defects. Trends Biotechnol. 11,
379–383.
Wilcox, J. N. (1993). Fundamental principles of in situ hybridiza-
tion. J. Histochem. Cytochem. 41, 1725–1733.
Wozney, J. M., Capparella, J., and Rosen, V. (1993). The bone
morphogenetic proteins in cartilage and bone development. In
“Molecular Basis of Morphogenesis” (M. Bernfield, Ed.), pp.
221–230. Wiley–Liss, New York.
Yu, K., Srinivasan, S., Shimmi, O., Biehs, B., Rashka, K. E.,
Kimelman, D., O’Connor, M. B., and Bier, E. (2000). Processing of
the Drosophila Sog protein creates a novel BMP inhibitory
activity. Development 127, 2143–2154.
Zhao, R., Lawler, A. M., and Lee, S. J. (1999). Characterization of
GDF-10 expression patterns and null mice. Dev. Biol. 212,
68–79. doi: 10.1006/dbio/1999.9326.
Zimmerman, L. B., De Jesus-Escobar, J. M., and Harland, R. M.
(1996). The Spemann organizer signal noggin binds and inacti-
vates bone morphogenetic protein 4. Cell 86, 599–606.
Received for publication September 11, 2000
Accepted January 23, 2001Published online March 16, 2001
s of reproduction in any form reserved.
